The Stem Cell Research Environment:A Patchwork of Patchworks

Few areas of recent research have received as much focus or generated as much excitement and debate as stem cell research. Hope for the therapeutic promise of this field has been matched by social concern associated largely with the sources of stem cells and their uses. This interplay between promise and controversy has contributed to the enormous variation that exists among the environments in which stem cell research is conducted throughout the world. This variation is layered upon intra-jurisdictional policies that are also often complex and in flux, resulting in what we term a 'patchwork of patchworks'. This patchwork of patchworks and its implications will become increasingly important as we enter this new era of stem cell research. The current progression towards translational and clinical research among international collaborators serves as a catalyst for identifying potential policy conflict and makes it imperative to address jurisdictional variability in stem cell research environments. The existing patchworks seen in contemporary stem cell research environments provide a valuable opportunity to consider how variations in regulations and policies across and within jurisdictions influence research efficiencies and directions. In one sense, the stem cell research context can be viewed as a living experiment occurring across the globe. The lessons to be gleaned from examining this field have great potential for broad-ranging general science policy application

Patients beware: commercialized stem cell treatments on the web

A report by the International Society for Stem Cell Research (ISSCR)'s Task Force on Unproven Stem Cell Treatments outlines development of resources for patients, their families, and physicians seeking information on stem cell treatment

Patients beware: commercialized stem cell treatments on the web

A report by the International Society for Stem Cell Research (ISSCR)'s Task Force on Unproven Stem Cell Treatments outlines development of resources for patients, their families, and physicians seeking information on stem cell treatments.Fil: Taylor, Patrick L.. Children’s Hospital Boston; Estados UnidosFil: Barker, Roger A.. University of Cambridge. Department of Clinical Neuroscience. Cambridge Centre for Brain Repair; Reino UnidoFil: Blume, Karl G.. University Of Stanford; Estados UnidosFil: Cattaneo, Elena. Universita Degli Studi Di Milano; ItaliaFil: Colman, Alan. A*STAR Singapore Stem Cell Consortium; SingapurFil: Deng, Hongkui. Peking University; República de ChinaFil: Edgar, Harold. Columbia Law School; Estados UnidosFil: Fox, Ira J.. Children’s Hospital of Pittsburgh of UPMC. McGowan Institute for Regenerative Medicine; Estados UnidosFil: Gerstle, Claude. Delray Beach; Estados UnidosFil: Goldstein, Lawrence S. B.. University Of California At San Diego; Estados UnidosFil: High, Katherine A.. The Children’s Hospital of Philadelphia; Estados UnidosFil: Lyall, Andrew. Stem Cell Network; CanadáFil: Parkman, Robertson. Children’s Hospital Los Angeles; Estados UnidosFil: Pitossi, Fernando Juan. Fundación Instituto Leloir; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Instituto de Investigaciones Bioquimicas de Buenos Aires; ArgentinaFil: Prentice, Ernest D.. University of Nebraska Medical Center; Estados UnidosFil: Rooke, Heather M.. International Society for Stem Cell Research; Estados UnidosFil: Sipp, Douglas A.. RIKEN Center for Developmental Biology; JapónFil: Srivastava, Alok. Christian Medical College; IndiaFil: Stayn, Susan. University Of Stanford; Estados UnidosFil: Steinberg, Gary K.. University Of Stanford; Estados UnidosFil: Wagers, Amy J.. Joslin Diabetes Center; Estados UnidosFil: Weissman, Irving L.. University Of Stanford; Estados Unido